Skip To Main Content
Carolyn E Cesta on Muck Rack

Carolyn E Cesta

As seen in: Nature, Wiley Online Library, BMJ Open Diabetes Research & Care, Evidence-Based Mental Health, SAGE Publishing, The Globe and Mail, JAMA (The Journal of the American Medical Association), JAMA Internal Medicine Author Interviews, JAMA: Journal of the American Medical Association, EClinicalMedicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Carolyn E

Contact Carolyn E, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Guiding Obstetric Care and Treatment Decisions for Women With Prior GLP-1 Receptor Agonist Use

|
By Carolyn E Cesta
| JAMA: Journal of the American Medical Association Verified
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as liraglutide and semaglutide, have revolutionized treatment of obesity.1 Obesity and obesity-related comorbidities increase the risks of adverse outcomes such as miscarriage, congenital malformations, preterm birth, gestational diabetes, and preeclampsia, which can have significant long-term consequences for mother and infant.2 By enabling women to begin pregnancy at a lower body mass index (BMI), GLP-1RAs have great potential to...
Open in Who Shared Issue with article?

Current Use of Common Data Models in the Nordic Countries

|
By Carolyn E Cesta, Jacqueline Cohen, Maarit K. Leinonen, Gerard Ompad
| Wiley Online Library Verified
Purpose Common data models (CDMs) standardize healthcare data to facilitate reproducible and consistent analyses, supporting decision-making in medicine and vaccine safety and pharmacoepidemiology. Despite their global recognition, the implementation and use of CDMs in the Nordic countries remain underexplored, particularly in the context of cross-national collaborations.
Open in Who Shared Issue with article?

Risk of Major Congenital Malformations Following Prenatal Exposure to Smoking Cessation Medicines

|
By Jacqueline Cohen, SARAH RADFORD and JENNIFER DONALD, Sarah Mac Donald Verified, Carolyn E Cesta
| JAMA Internal Medicine Author Interviews
Key Points Question Is the use of nicotine replacement therapy (NRT), varenicline, and bupropion during the first trimester of pregnancy associated with increased risks of major congenital malformations (MCMs)? Findings In this cohort study of 5.2 million births in Australia (state of New South Wales), New Zealand, Norway, and Sweden, there was no increased risk of MCMs overall following exposure to NRT (9325 infants), varenicline (3031 infants), or bupropion (1042 infants).
Open in Who Shared Issue with article?
See all 21 articles